Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commercial

Set Alert for Commercial

Brain Therapies Leads Medtronic’s Growth In First Quarter Of Fiscal 2020

The medtech giant reported revenue of $7.5bn in the quarter that ended on 26 July, up 3.5% year-over-year basis, led by 12.5% growth in revenues from emerging markets. Medtronic’s fastest-growing business is its brain therapies unit, which reported 11.4% growth in the quarter.

Sales & Earnings Innovation Orthopedics
Advertisement

Companies

Set Alert for Companies

Latest From Companies

Roche Diagnostics Sees Data Sourcing, AI and Partnerships As Paving The Way to Personalized Health Care, But Challenges Remain

Two Roche Diagnostics executives outlined the company's vision toward personalized health care. Machine learning, partnerships and data sourcing are key. 

Personalized Medicine Business Strategies

Execs On The Move: Operating And Science Appointments At Accelerate And BioTelemetry; Leadership Change At Revenio

In vitro testing company Accelerate Diagnostics fills COO slot; remote medical technology firm BioTelemetry appoints a CMO; a new chief executive is in place at medical measuring instruments-maker Revenio Group; and more.

Appointments Commercial

Boston Scientific Closes Multibillion-Dollar BTG Deal

Boston Scientific has completed the acquisition of UK interventional medicine specialist BTG. The deal, which was announced in November last year is Boston Scientific’s biggest since its controversial 2006 acquisition of heart device maker Guidant Corp. for $27bn.

M & A Deals
See All

Deals and Financings

Set Alert for Deals

Latest From Deals

Boston Scientific Closes Multibillion-Dollar BTG Deal

Boston Scientific has completed the acquisition of UK interventional medicine specialist BTG. The deal, which was announced in November last year is Boston Scientific’s biggest since its controversial 2006 acquisition of heart device maker Guidant Corp. for $27bn.

M & A Deals

QUOTED. 19 August 2019. Michael Carrel.

AtriCure Inc. has closed a $300m structured deal to acquire SentreHEART Inc., the privately held developer of the Lariat percutaneous left atrial appendage (LAA) closure device. See what AtriCure CEO Michael Carrel said about it here.

Quoted Deals

AtriCure Adds Lariat LAA Closure System With $300M SentreHeart Acquisition

AtriCure Inc. has closed a $300m structured deal to acquire SentreHEART Inc., a privately held developer of percutaneous left atrial appendage management solutions.

Cardiovascular M & A
See All

Market Access

Set Alert for Market Access

Latest From Market Access

Sir Andrew Dillon Standing Down As Head Of England’s NICE After 20 Years

Sir Andrew Dillon is stepping down from what has been described as one of the most challenging and potentially controversial roles in British public life.

Health Technology Assessment United Kingdom

Medtronic, Capital District Physicians’ Health Plan Partner To 'Gamify' Diabetes Control

Health plan members will be invited to join Medtronic’s Inner Circle patient engagement program, which applies game design to help motivate and encourage patients with diabetes to achieve monthly health-outcome goals.

Commercial Healthcare Systems

The Digital Opportunity Must Be Shaped By Healthtech, Say UK Medtechs

The UK continues to build its digital health-care infrastructure, as seen in last week’s government funding pledge for a new AI lab. But this is set against criticism of the lack of digital resources at health-care providers. As the ABHI’s newly appointed digital health lead, Andrew Davies says stakeholders first need to understand the scope and needs of digital health care, and then adopt a networked approach, with medtech playing a full part in the helping the system evolve appropriately.

United Kingdom Digital Health
See All

Market Intelligence

Set Alert for Market Intelligence

Latest From Market Intelligence

QUOTED. 21 August 2019. David Smith.

The largest diagnostics companies, including Roche Diagnostics Corp., showcased their latest products at the recent American Association for Clinical Chemistry's (AACC) conference in Anaheim. See what David Smith, regional business manager for Roche's Navify decision-support portfolio, said about it here.

Quoted Market Intelligence

Market Intel: AACC 2019 – Roundup Of The Top 5 Diagnostics Companies

The recent AACC annual meeting drew more than 20,000 laboratory professionals to the Anaheim Convention Center. Medtech Insight caught up with the leading companies in the diagnostics space for a roundup of their latest product offerings and new developments. 

Market Intelligence Diagnostics

Marketing Can Provide Solutions For Medtech

In an interview with Medtech Insight, ZS' medtech marketing experts Matt Singer and Sundeep Karnik explain how companies can gain an competitive advantage by investing in their marketing operations, rather than restructuring their sales team, adding or subtracting new products, or overhauling their R&D programs.

Business Strategies Market Access
See All

Appointments

Set Alert for Appointments

Latest From Appointments

Execs On The Move: Operating And Science Appointments At Accelerate And BioTelemetry; Leadership Change At Revenio

In vitro testing company Accelerate Diagnostics fills COO slot; remote medical technology firm BioTelemetry appoints a CMO; a new chief executive is in place at medical measuring instruments-maker Revenio Group; and more.

Appointments Commercial

Execs On The Move: Foundation Medicine And OneOme Hire New Chief Officers; Insulet And Quanterix See Board Changes

Genomic profiling firm Foundation Medicine snags top Roche Genentech cancer researcher as new CSO; OneOme, a health-care tech company, hires new CEO; Insulet and Quanterix hire new directors; and more.

Appointments Commercial

Execs On The Move: New Appointments And Promotions At Cutera, Merit Medical And NeuroPace

Energy-based aesthetics systems developer Cutera poached its CEO from Vyaire; disposable equipment-maker Merit Medical appointed a physician as the new chief wellness officer; the acting sales leader at NeuroPace, a neurostimulator-maker, was promoted to CEO; and more.

Appointments Commercial
See All
UsernamePublicRestriction

Register